Product image of Infectociprocort (Ciprofloxacin, Fluocinolone Acetonide) supplied by GNH India

Infectociprocort

Active Ingredient:
Ciprofloxacin, Fluocinolone Acetonide
Origin:
EU

Infectociprocort (Ciprofloxacin, Fluocinolone Acetonide)

Ciprofloxacin and Fluocinolone Acetonide, the active ingredients in Infectociprocort, are a fluoroquinolone and a corticosteroid presented as an auricular preparation for ear use. The combination provides antibacterial activity together with local anti‑inflammatory effect for ear conditions.
GNH India supplies Infectociprocort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pädia Gmbh, De, Heppenheim

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Infectociprocort is indicated for ear conditions where bacterial infection and inflammation coexist.
  • Otitis externa: reduces bacterial load and alleviates inflammation in the external auditory canal.
  • Bacterial ear infection with inflammatory component: treats the infection while controlling local swelling and pain.
  • Post‑traumatic ear canal inflammation: helps prevent secondary infection and eases inflammatory symptoms.

How It Works

  • Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, blocking DNA replication and leading to bacterial cell death. Fluocinolone acetonide binds to intracellular glucocorticoid receptors, altering gene transcription to suppress the release of inflammatory mediators, thereby reducing local swelling, erythema, and pain.

Side Effects

Infectociprocort may cause local and systemic adverse reactions.

Common Side Effects

  • Ear discomfort or burning sensation.
  • Pruritus or mild irritation of the ear canal.
  • Transient redness or swelling at the application site.
  • Temporary hearing changes that resolve after treatment.
  • Mild headache.
  • Nausea (rare with systemic absorption).

Serious or Rare Side Effects

  • Allergic reaction: rash, urticaria, or angioedema.
  • Ototoxicity: persistent hearing loss or vestibular dysfunction.
  • Severe local inflammation or ulceration.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Systemic fluoroquinolone effects: tendon rupture, QT prolongation.
  • Corticosteroid‑related adrenal suppression with prolonged use.

Precautions & Warnings

  • Use Infectociprocort only under medical supervision and consider the following precautions.
  • Pregnancy: consult a healthcare professional before use; safety data are limited.
  • Breastfeeding: evaluate risk versus benefit, as small amounts may be excreted in milk.
  • Allergy: avoid if known hypersensitivity to ciprofloxacin, fluoroquinolones, or corticosteroids.
  • Perforated tympanic membrane: use only if advised, as systemic absorption may increase.
  • Concurrent ototoxic drugs: monitor hearing function when used with aminoglycosides or loop diuretics.
  • Store at room temperature: keep in the original container, protect from moisture and direct light.

Avoid Interactions

Infectociprocort can interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid)

  • Systemic fluoroquinolones: additive toxicity and increased risk of tendon disorders.
  • Ototoxic agents (e.g., aminoglycosides, loop diuretics): heightened risk of hearing loss.
  • Live vaccines: systemic immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antacids containing magnesium or aluminum: may reduce ciprofloxacin absorption; separate dosing by at least 2 hours.
  • CYP450 inhibitors (e.g., ketoconazole): can increase fluocinolone levels.
  • NSAIDs: may increase risk of gastrointestinal irritation.
  • Warfarin: monitor INR as fluoroquinolones can potentiate anticoagulant effect.

Frequently Asked Questions

Infectociprocort is prescribed for ear infections where bacterial growth and inflammation are present, such as otitis externa and other bacterial ear infections with an inflammatory component. It combines an antibacterial fluoroquinolone with a corticosteroid to address both infection and swelling.

Ciprofloxacin blocks bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and leading to bacterial death. Fluocinolone acetonide binds glucocorticoid receptors, altering gene expression to suppress inflammatory mediators, thereby reducing local swelling, redness, and pain.

The dosage regimen for Infectociprocort is determined by the prescribing clinician based on the severity of the ear condition, patient age, and other clinical factors. Patients should follow the specific instructions provided by their healthcare professional.

Safety data for Infectociprocort in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To request Infectociprocort, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with single‑agent ear antibiotics, Infectociprocort offers both antibacterial and anti‑inflammatory actions in one formulation, potentially reducing the need for separate steroid drops. This dual mechanism can simplify treatment regimens for infections that also cause significant inflammation.

Store Infectociprocort at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Infectociprocort is applied directly into the ear canal as an otic preparation. The patient should lie with the treated ear facing upward, instill the prescribed number of drops, and remain in that position for a few minutes to allow adequate distribution.

Serious risks include allergic reactions such as rash, urticaria, or angioedema, and ototoxicity that may lead to permanent hearing loss or balance disturbances, especially when used with other ototoxic drugs or in patients with a perforated tympanic membrane.

Patients with known hypersensitivity to ciprofloxacin, other fluoroquinolones, fluocinolone acetonide, or any component of the formulation should avoid this product. It is also contraindicated in individuals with certain ear conditions, such as a ruptured tympanic membrane, unless specifically directed by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciprofloxacin, Fluocinolone Acetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT